标题
Somatic variation and cancer: therapies lost in the mix
作者
关键词
-
出版物
HUMAN GENETICS
Volume 130, Issue 1, Pages 79-91
出版商
Springer Nature
发表日期
2011-06-04
DOI
10.1007/s00439-011-1010-0
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Genomic Pathology: Challenges for Implementation
- (2011) Philip T Cagle et al. ARCHIVES OF PATHOLOGY & LABORATORY MEDICINE
- Identification of a Novel TP53 Cancer Susceptibility Mutation Through Whole-Genome Sequencing of a Patient With Therapy-Related AML
- (2011) Daniel C. Link JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Charting a course for genomic medicine from base pairs to bedside
- (2011) Eric D. Green et al. NATURE
- Targeting the missing links for cancer therapy
- (2011) Kornelia Polyak et al. NATURE MEDICINE
- A close look at cancer
- (2011) Alison Farrell NATURE MEDICINE
- Cancer epigenetics reaches mainstream oncology
- (2011) Manuel Rodríguez-Paredes et al. NATURE MEDICINE
- Taming the dragon: genomic biomarkers to individualize the treatment of cancer
- (2011) Ian J Majewski et al. NATURE MEDICINE
- Cancer genomics: from discovery science to personalized medicine
- (2011) Lynda Chin et al. NATURE MEDICINE
- Predictive, personalized, preventive, participatory (P4) cancer medicine
- (2011) Leroy Hood et al. Nature Reviews Clinical Oncology
- Personalized cancer medicine: era of promise and progress
- (2011) Lisa Hutchinson Nature Reviews Clinical Oncology
- WIN Consortium—challenges and advances
- (2011) John Mendelsohn et al. Nature Reviews Clinical Oncology
- Implications of personalized medicine—perspective from a cancer center
- (2011) Thomas Tursz et al. Nature Reviews Clinical Oncology
- Biomarker studies: a call for a comprehensive biomarker study registry
- (2011) Fabrice Andre et al. Nature Reviews Clinical Oncology
- Methodological and practical challenges for personalized cancer therapies
- (2011) Ignacio I. Wistuba et al. Nature Reviews Clinical Oncology
- An accelerated pathway for targeted cancer therapies
- (2011) Mark McClellan et al. NATURE REVIEWS DRUG DISCOVERY
- Advances in the preclinical testing of cancer therapeutic hypotheses
- (2011) Giordano Caponigro et al. NATURE REVIEWS DRUG DISCOVERY
- Phase III and submission failures: 2007–2010
- (2011) John Arrowsmith NATURE REVIEWS DRUG DISCOVERY
- Genomics and the Continuum of Cancer Care
- (2011) Ultan McDermott et al. NEW ENGLAND JOURNAL OF MEDICINE
- Resistance to BRAF Inhibition in Melanomas
- (2011) David B. Solit et al. NEW ENGLAND JOURNAL OF MEDICINE
- Using genetics and genomics strategies to personalize therapy for cancer: Focus on melanoma
- (2010) Katherine L. Nathanson BIOCHEMICAL PHARMACOLOGY
- Molecular predictors of outcome in a phase 3 study of gemcitabine and erlotinib therapy in patients with advanced pancreatic cancer
- (2010) Gilda da Cunha Santos et al. CANCER
- ALK Inhibition for Non-Small Cell Lung Cancer: From Discovery to Therapy in Record Time
- (2010) David E. Gerber et al. CANCER CELL
- Striving to Improve Outcomes in Oncology: Unmet Expectations in a Complex Disease
- (2010) S. E. Bates CLINICAL CANCER RESEARCH
- Translating Clinical Trials into Meaningful Outcomes
- (2010) P. M. LoRusso et al. CLINICAL CANCER RESEARCH
- AACR-FDA-NCI Cancer Biomarkers Collaborative Consensus Report: Advancing the Use of Biomarkers in Cancer Drug Development
- (2010) S. N. Khleif et al. CLINICAL CANCER RESEARCH
- Identifying pancreatic cancer patients for targeted treatment: the challenges and limitations of the current selection process and vision for the future
- (2010) Shayna L Showalter et al. Expert Opinion on Drug Delivery
- Clinical Implications of the Cancer Genome
- (2010) Laura E. MacConaill et al. JOURNAL OF CLINICAL ONCOLOGY
- Selecting Systemic Cancer Therapy One Patient at a Time: Is There a Role for Molecular Profiling of Individual Patients With Advanced Solid Tumors?
- (2010) James H. Doroshow JOURNAL OF CLINICAL ONCOLOGY
- Pilot Study Using Molecular Profiling of Patients' Tumors to Find Potential Targets and Select Treatments for Their Refractory Cancers
- (2010) Daniel D. Von Hoff et al. JOURNAL OF CLINICAL ONCOLOGY
- Adaptive Clinical Trial Design: Has Its Time Come?
- (2010) N. J. Nelson JNCI-Journal of the National Cancer Institute
- Randomized Clinical Trials With Biomarkers: Design Issues
- (2010) B. Freidlin et al. JNCI-Journal of the National Cancer Institute
- When Are "Positive" Clinical Trials in Oncology Truly Positive?
- (2010) A. Ocana et al. JNCI-Journal of the National Cancer Institute
- Trastuzumab in combination with chemotherapy versus chemotherapy alone for treatment of HER2-positive advanced gastric or gastro-oesophageal junction cancer (ToGA): a phase 3, open-label, randomised controlled trial
- (2010) Yung-Jue Bang et al. LANCET
- Personalizing Cancer Treatment in the Age of Global Genomic Analyses: PALB2 Gene Mutations and the Response to DNA Damaging Agents in Pancreatic Cancer
- (2010) M. C. Villarroel et al. MOLECULAR CANCER THERAPEUTICS
- COT drives resistance to RAF inhibition through MAP kinase pathway reactivation
- (2010) Cory M. Johannessen et al. NATURE
- Melanomas acquire resistance to B-RAF(V600E) inhibition by RTK or N-RAS upregulation
- (2010) Ramin Nazarian et al. NATURE
- International network of cancer genome projects
- (2010) Thomas J. Hudson (Chairperson) et al. NATURE
- Rearrangements of the RAF kinase pathway in prostate cancer, gastric cancer and melanoma
- (2010) Nallasivam Palanisamy et al. NATURE MEDICINE
- Understanding resistance to EGFR inhibitors—impact on future treatment strategies
- (2010) Deric L. Wheeler et al. Nature Reviews Clinical Oncology
- Gene and drug matrix for personalized cancer therapy
- (2010) Tim Harris NATURE REVIEWS DRUG DISCOVERY
- Personalized medicine in oncology: the future is now
- (2010) Richard L. Schilsky NATURE REVIEWS DRUG DISCOVERY
- Genomics drugs in clinical trials
- (2010) Jonathan Hall et al. NATURE REVIEWS DRUG DISCOVERY
- Absolute benefits of medical therapies in phase III clinical trials for breast and colorectal cancer
- (2009) B. Seruga et al. ANNALS OF ONCOLOGY
- Changing the Paradigm in Conducting Randomized Clinical Studies in Advanced Pancreatic Cancer: An Opportunity for Better Clinical Development
- (2009) Josep Tabernero et al. JOURNAL OF CLINICAL ONCOLOGY
- American Society of Clinical Oncology Provisional Clinical Opinion: Testing forKRASGene Mutations in Patients With Metastatic Colorectal Carcinoma to Predict Response to Anti–Epidermal Growth Factor Receptor Monoclonal Antibody Therapy
- (2009) Carmen J. Allegra et al. JOURNAL OF CLINICAL ONCOLOGY
- Clinical Trial Designs for Predictive Biomarker Validation: Theoretical Considerations and Practical Challenges
- (2009) Sumithra J. Mandrekar et al. JOURNAL OF CLINICAL ONCOLOGY
- Consensus Report of the National Cancer Institute Clinical Trials Planning Meeting on Pancreas Cancer Treatment
- (2009) Philip A. Philip et al. JOURNAL OF CLINICAL ONCOLOGY
- The cancer genome
- (2009) Michael R. Stratton et al. NATURE
- Molecular predictors of response to trastuzumab and lapatinib in breast cancer
- (2009) Francisco J. Esteva et al. Nature Reviews Clinical Oncology
- HER2-testing in 538 consecutive breast cancer cases using FISH and immunohistochemistry
- (2009) Anikó Kovács et al. PATHOLOGY RESEARCH AND PRACTICE
- Profiling Critical Cancer Gene Mutations in Clinical Tumor Samples
- (2009) Laura E. MacConaill et al. PLoS One
- Response to neoadjuvant therapy with cisplatin in BRCA1-positive breast cancer patients
- (2008) T. Byrski et al. BREAST CANCER RESEARCH AND TREATMENT
- Coordinated Epidermal Growth Factor Receptor Pathway Gene Overexpression Predicts Epidermal Growth Factor Receptor Inhibitor Sensitivity in Pancreatic Cancer
- (2008) A. Jimeno et al. CANCER RESEARCH
- Translating insights from the cancer genome into clinical practice
- (2008) Lynda Chin et al. NATURE
- Comprehensive genomic characterization defines human glioblastoma genes and core pathways
- (2008) Roger McLendon et al. NATURE
- Oncogenes and Cancer
- (2008) Carlo M. Croce NEW ENGLAND JOURNAL OF MEDICINE
- K-rasMutations and Benefit from Cetuximab in Advanced Colorectal Cancer
- (2008) Christos S. Karapetis et al. NEW ENGLAND JOURNAL OF MEDICINE
- Core Signaling Pathways in Human Pancreatic Cancers Revealed by Global Genomic Analyses
- (2008) S. Jones et al. SCIENCE
- An Integrated Genomic Analysis of Human Glioblastoma Multiforme
- (2008) D. W. Parsons et al. SCIENCE
Become a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get StartedAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started